Home › NDC Lookup › RxCUI directory › RxCUI 311028

Insulin isophane, human 100 UNT/ML Injectable Suspension — RxCUI 311028

Name: Insulin isophane, human 100 UNT/ML Injectable Suspension (RxCUI 311028)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 311028 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311028

Official nameInsulin isophane, human 100 UNT/ML Injectable Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asinsulin isophane (NPH), human 100 UNT/ML Injectable Suspension

FDA products mapped4

Package NDCs mapped6

Reported Medicaid activity (SDUD)146,918 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Insulin isophane, human 100 UNT/ML Injectable Su... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Insulin isophane, human 100 UNT/ML Injectable Suspension RxCUI 311028 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Insulin isophane 1605101 IN
- Insulin isophane, human 253181 PIN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Humulin N 92880 BN
- Novolin N 93558 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin isophane Injectable Suspension 378928 SCDF
- Insulin isophane, human Injectable Suspension 2647860 SCDFP
- Insulin isophane Injectable Product 1653897 SCDG
- Insulin isophane, human Injectable Product 2662172 SCDGP
- Insulin isophane Injectable Suspension [Humulin N] 365677 SBDF
- Insulin isophane Injectable Suspension [Novolin N] 365573 SBDF
- Insulin isophane, human Injectable Suspension [Humulin N] 2656578 SBDFP
- Insulin isophane, human Injectable Suspension [Novolin N] 2657264 SBDFP
- +4 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Insulin isophane, human 100 UNT/ML 343101 SCDC
- Insulin isophane, human 100 UNT/ML Injectable Suspension [Humulin N] 311026 SBD
- Insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N] 311027 SBD
- Insulin isophane, human 100 UNT/ML [Humulin N] 575141 SBDC
- Insulin isophane, human 100 UNT/ML [Novolin N] 575142 SBDC

Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Insulin isophane, human 100 UNT/ML SCDC · 343101
Insulin isophane Injectable Suspension SCDF · 378928
Insulin isophane, human Injectable Suspension SCDFP · 2647860
Insulin isophane Injectable Product SCDG · 1653897
Insulin isophane, human Injectable Product SCDGP · 2662172

Brand-Name Concepts

Insulin isophane, human 100 UNT/ML Injectable Suspension [Humulin N] SBD · 311026
Insulin isophane, human 100 UNT/ML Injectable Suspension [Novolin N] SBD · 311027
Insulin isophane, human 100 UNT/ML [Humulin N] SBDC · 575141
Insulin isophane, human 100 UNT/ML [Novolin N] SBDC · 575142
Insulin isophane Injectable Suspension [Humulin N] SBDF · 365677
Insulin isophane Injectable Suspension [Novolin N] SBDF · 365573
Insulin isophane, human Injectable Suspension [Humulin N] SBDFP · 2656578
Insulin isophane, human Injectable Suspension [Novolin N] SBDFP · 2657264
Humulin N Injectable Product SBDG · 1172691
Novolin N Injectable Product SBDG · 1178127

📦 FDA Products & Package NDCs

4 products · 6 package NDCs

6 package NDCs map to RxCUI 311028 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00002-8315-01	1 VIAL, MULTI-DOSE in 1 CARTON (0002-8315-01) / 10 mL in 1...	Humulin N	Eli Lilly and Company	1983-06-27
00002-8805-59	5 SYRINGE in 1 CARTON (0002-8805-59) / 3 mL in 1 SYRINGE (0...	Humulin N	Eli Lilly and Company	2014-01-17
00169-1834-02	1 VIAL in 1 CARTON (0169-1834-02) / 10 mL in 1 VIAL	Novolin N	Novo Nordisk	1991-07-01
00169-1834-11	1 VIAL in 1 CARTON (0169-1834-11) / 10 mL in 1 VIAL	Novolin N	Novo Nordisk	1991-07-01
00169-3004-15	5 SYRINGE, PLASTIC in 1 CARTON (0169-3004-15) / 3 mL in 1 S...	Novolin N	Novo Nordisk	2019-09-06
00169-3004-25	5 SYRINGE, PLASTIC in 1 CARTON (0169-3004-25) / 3 mL in 1 S...	Novolin N	Novo Nordisk	2019-09-06

Observed labelers: Novo Nordisk (4) · Eli Lilly and Company (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$5.2231

Range $4.2660–$9.0378 · middle 50% $4.5332–$6.6274 · 4 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.